mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.25 |
0.02 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.03 |
mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.03 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.03 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.03 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.04 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.04 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.04 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.05 |